Drug Type Small molecule drug |
Synonyms Carmen, Corifeo, Lercadip + [25] |
Target |
Mechanism Cav2.1 inhibitors(calcium voltage-gated channel subunit alpha1 A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date SE (28 Mar 1998), |
RegulationPriority Review (CN) |
Molecular FormulaC36H42ClN3O6 |
InChIKeyWMFYOYKPJLRMJI-UHFFFAOYSA-N |
CAS Registry132866-11-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01849 | Lercanidipine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | SE | 28 Mar 1998 |
Phase 2 | 1,039 | Placebo | wvhjfagjxf(bcylxioknv) = jdqkavglvf blzndyayxk (qgbmgdcoak ) View more | - | 01 Jan 2016 | ||
Lercanidipine 10mg | wvhjfagjxf(bcylxioknv) = srtnxbxzwz blzndyayxk (qgbmgdcoak ) View more |